S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
S&P 500   4,585.37 (-1.50%)
DOW   34,588.06 (-1.56%)
QQQ   393.36 (-1.58%)
AAPL   163.68 (+2.15%)
MSFT   330.57 (-1.80%)
FB   326.50 (-3.41%)
GOOGL   2,850.91 (-2.05%)
AMZN   3,502.05 (-1.67%)
TSLA   1,127.92 (-0.80%)
NVDA   322.29 (-3.44%)
BABA   127.35 (-3.24%)
NIO   38.85 (-3.98%)
CGC   10.45 (-5.52%)
AMD   156.97 (-3.05%)
GE   94.86 (-3.60%)
MU   84.62 (-1.76%)
T   22.65 (-5.19%)
F   19.19 (-2.44%)
DIS   144.16 (-2.47%)
ACB   6.23 (-3.26%)
AMC   33.82 (-8.20%)
PFE   54.20 (+3.44%)
BA   194.78 (-1.87%)
NASDAQ:APVO

Aptevo Therapeutics Short Interest Ratio and Short Volume

$9.80
-0.73 (-6.93%)
(As of 11/30/2021 01:21 PM ET)
Add
Compare
Today's Range
$9.50
$11.27
50-Day Range
$6.48
$17.49
52-Week Range
$6.38
$51.75
Volume
106,083 shs
Average Volume
9.99 million shs
Market Capitalization
$48.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
6.74

Aptevo Therapeutics (NASDAQ:APVO) Short Interest Data

Current Short Volume
87,300 shares
Previous Short Volume
83,200 shares
Change Vs. Previous Month
+4.93%
Dollar Volume Sold Short
$848.56 thousand
Short Interest Ratio / Days to Cover
0.0
Last Record Date
November, 15 2021
Outstanding Shares
4,900,000 shares
Percentage of Shares Shorted
1.78%
Today's Trading Volume
106,083 shares
Average Trading Volume
9,989,045 shares
Today's Volume Vs. Average
-98.94%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Aptevo Therapeutics ?

Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Aptevo Therapeutics (NASDAQ:APVO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/202187,300 shares $848.56 thousand +4.9%N/A0 $9.72
10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24
10/15/202162,900 shares $942.87 thousand +4.7%N/A1.4 $14.99
9/30/202160,100 shares $927.94 thousand -6.1%N/A1.2 $15.44
9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14
8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95
8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00
7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77
7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75
6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43
6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00
5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12
5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93
4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34
4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57
3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20
3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97
2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62
2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76
1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83
1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82
12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11
12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61
11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39
11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98

Institutional Investors Shorting Aptevo Therapeutics (NASDAQ:APVO)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of Aptevo Therapeutics. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
11/9/2021Concourse Financial Group Securities Inc.N/A0N/A$0.00













Aptevo Therapeutics (NASDAQ:APVO) Short Interest Frequently Asked Questions

What is Aptevo Therapeutics' current short interest?

Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 87,300 shares of APVO short. Learn More on Aptevo Therapeutics' current short interest.

Which institutional investors are shorting Aptevo Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Aptevo Therapeutics' short interest increasing or decreasing?

Aptevo Therapeutics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 87,300 shares, an increase of 4.9% from the previous total of 83,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Aptevo Therapeutics' short interest compare to its competitors?

0.00% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aptevo Therapeutics: 180 Life Sciences Corp. (0.00%), Inozyme Pharma, Inc. (1.49%), Athenex, Inc. (4.96%), Infinity Pharmaceuticals, Inc. (2.54%), Mustang Bio, Inc. (8.31%), Alzamend Neuro, Inc. (7.13%), Frequency Therapeutics, Inc. (14.47%), TFF Pharmaceuticals, Inc. (2.51%), NexImmune, Inc. (2.79%), and Seelos Therapeutics, Inc. (7.92%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Aptevo Therapeutics stock?

Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. Aptevo Therapeutics' stock is trading down $0.73 today. To short Aptevo Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Aptevo Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aptevo Therapeutics?

A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further.

How often is Aptevo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.